A novel retinoic acid drug, EYE-502, inhibits choroidal neovascularization by targeting endothelial cells and pericytes

Choroidal neovascularization (CNV) occurs in neovascular age-related macular degeneration (AMD) and often leads to permanent visual impairment. Intravitreal injection of anti-vascular endothelial growth factor (VEGF) agents is the gold standard for the treatment of CNV. However, anti-VEGF treatment...

Descripción completa

Detalles Bibliográficos
Autores principales: Shen, Yaming, Xu, Miao, Ren, Ling, Li, Xiumiao, Han, Xiaoyan, Cao, Xin, Yao, Jin, Yan, Biao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10300120/
https://www.ncbi.nlm.nih.gov/pubmed/37369771
http://dx.doi.org/10.1038/s41598-023-37619-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10300120/
https://www.ncbi.nlm.nih.gov/pubmed/37369771
http://dx.doi.org/10.1038/s41598-023-37619-7

Ejemplares similares